Rocuronium Bromide 50 mg/ Injection Solution recalled over sterility concerns
- Recall date
- November 18, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Cantrell Drug Company recalls Rocuronium Bromide 50 mg/5 mL Injection Solution, 5 mL (10 mg/mL) Single-Dose Syringe, Injection Solution For Slow IV U…
- Recall number
- D-0202-2017
- FDA classification
- Class II
- Brand / firm
- Cantrell Drug Company
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Rocuronium Bromide 50 mg/5 mL Injection Solution, 5 mL (10 mg/mL) Single-Dose Syringe, Injection Solution For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-064-15
Get recall alerts
Free email alert whenever Cantrell Drug Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cantrell Drug Company